{"id":"W3158669775","doi":"10.1093/rheumatology/keab381","title":"Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus","year":2021,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"National Institute for Health and Care Research","keywords":"Medicine; Placebo; Adverse effect; Systemic lupus erythematosus; Internal medicine; Lupus erythematosus; Proteinuria; Randomized controlled trial; Prednisone; Clinical trial; Immunology; Disease; Antibody; Kidney","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009614991,0.0004552436,0.003443759,0.0004721997,0.00006924785,0.00004658817,0.0002635542,0.0002618584,0.0001534812],"category_scores_gemma":[0.001643514,0.0003261633,0.0003993979,0.0007021295,0.0001232594,0.0001619054,0.0001417841,0.000452383,0.00006516741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004359951,"about_ca_system_score_gemma":0.0009003873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005600717,"about_ca_topic_score_gemma":0.0000344022,"domain_scores_codex":[0.9946749,0.001034407,0.001372611,0.0007441984,0.001470966,0.0007028845],"domain_scores_gemma":[0.9962496,0.001098909,0.000447682,0.001002743,0.0008432923,0.000357781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9854015,0.003075207,0.005349659,0.0008741384,0.0009077705,0.0005159164,0.002858944,0.00008372444,0.0003303341,0.0001240902,0.0001882387,0.0002904722],"study_design_scores_gemma":[0.987619,0.001652222,0.00002174107,0.00204046,0.0003596335,0.004710222,0.00116298,0.001244258,0.0007971367,0.0000571149,0.00002374532,0.00031143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805591,0.0003505387,0.0002672535,0.0001692612,0.000453414,0.01477841,0.00006062285,0.00006415264,0.003297262],"genre_scores_gemma":[0.9954016,0.00002879437,0.0002714667,0.0000663148,0.0001540602,0.001824827,0.00008357303,0.0000947419,0.002074626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01484251,"threshold_uncertainty_score":0.9999191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01359725788647897,"score_gpt":0.2824768056069135,"score_spread":0.2688795477204345,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}